| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |